ATE555384T1 - Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika - Google Patents
Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutikaInfo
- Publication number
- ATE555384T1 ATE555384T1 AT08011630T AT08011630T ATE555384T1 AT E555384 T1 ATE555384 T1 AT E555384T1 AT 08011630 T AT08011630 T AT 08011630T AT 08011630 T AT08011630 T AT 08011630T AT E555384 T1 ATE555384 T1 AT E555384T1
- Authority
- AT
- Austria
- Prior art keywords
- testing
- response
- cells
- action
- therapeutic drugs
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08011630A EP2138844B1 (de) | 2008-06-26 | 2008-06-26 | Verfahren zum Testen der Reaktion von Zellen auf die Einwirkung von Therapeutika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555384T1 true ATE555384T1 (de) | 2012-05-15 |
Family
ID=40152534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08011630T ATE555384T1 (de) | 2008-06-26 | 2008-06-26 | Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20090325178A1 (de) |
| EP (1) | EP2138844B1 (de) |
| AT (1) | ATE555384T1 (de) |
| CA (1) | CA2670484A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2642276A1 (de) * | 2012-03-22 | 2013-09-25 | Inoviem Scientific | Verfahren zur dynamischen Spektroskopie unter physiologischen Zuständen |
| RU2653442C2 (ru) * | 2015-12-29 | 2018-05-08 | Федеральное государственное бюджетное учреждение науки Институт теоретической и экспериментальной биофизики Российской академии наук (ИТЭБ РАН) | Способ персонифицированного скрининга действия препаратов на лейкозные клетки ex vivo |
| CN106859800B (zh) * | 2017-02-27 | 2018-03-06 | 滨州医学院 | 一种肿瘤种植器 |
| CN112316993B (zh) * | 2020-10-30 | 2022-04-08 | 临沂大学 | 一种单细胞阵列的获取方法 |
| CN116615654A (zh) * | 2020-11-24 | 2023-08-18 | 杜克大学 | 基于液滴类器官的免疫肿瘤学分析及其使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023172A (en) * | 1986-07-14 | 1991-06-11 | The Research Foundation Of State University Of New York | Predictive assay for tumor control |
| US5026650A (en) | 1988-06-30 | 1991-06-25 | The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration | Horizontally rotated cell culture system with a coaxial tubular oxygenator |
| US5155034A (en) | 1988-06-30 | 1992-10-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Three-dimensional cell to tissue assembly process |
| US5153131A (en) | 1990-12-11 | 1992-10-06 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High aspect reactor vessel and method of use |
| US4988623A (en) | 1988-06-30 | 1991-01-29 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Rotating bio-reactor cell culture apparatus |
| US5356793A (en) | 1990-03-15 | 1994-10-18 | Nitta Gelatin Inc. | Method for testing the sensitivity of anticancer drug |
| ATE238811T1 (de) | 1998-07-06 | 2003-05-15 | Janssen Pharmaceutica Nv | Inhibitoren von farnesylprotein-transferase mit radiosensibilisierenden eigenschaften |
| CN101437549A (zh) | 2006-05-08 | 2009-05-20 | 日立化成工业株式会社 | 通过对薄切肿瘤组织中mRNA表达进行定量测试实体瘤中药物敏感性的方法 |
-
2008
- 2008-06-26 AT AT08011630T patent/ATE555384T1/de active
- 2008-06-26 EP EP08011630A patent/EP2138844B1/de active Active
-
2009
- 2009-06-26 CA CA002670484A patent/CA2670484A1/en not_active Abandoned
- 2009-06-26 US US12/492,630 patent/US20090325178A1/en not_active Abandoned
-
2015
- 2015-09-04 US US14/845,432 patent/US20150377863A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2138844B1 (de) | 2012-04-25 |
| US20150377863A1 (en) | 2015-12-31 |
| EP2138844A1 (de) | 2009-12-30 |
| US20090325178A1 (en) | 2009-12-31 |
| CA2670484A1 (en) | 2009-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011156734A3 (en) | Method of characterizing vascular diseases | |
| DOP2019000287A (es) | Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi) | |
| WO2013158309A3 (en) | Non-disruptive gene targeting | |
| HK1185516A1 (zh) | 使用乳酸作為指示劑用於離體器官護理的系統和方法 | |
| ATE462787T1 (de) | Reversibles sirna-silencing eines mutierten und endogenen huntington-wildtypgens und dessen anwendung zur behandlung von morbus huntington | |
| WO2010105275A3 (en) | Method to assess human allograft status from microrna expression levels | |
| BR112015023120A2 (pt) | método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado | |
| AR085397A1 (es) | Combinacion de inhibidores de quinasa y sus usos | |
| CY1119262T1 (el) | Αναλυτικες μεθοδοι και συστοιχιες για χρηση στην ταυτοποιηση παραγοντων που επαγουν ευαισθητοποιηση στο ανθρωπινο δερμα | |
| WO2010062960A3 (en) | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE | |
| EA201390147A1 (ru) | Система циркуляции | |
| UY33826A (es) | Proteínas de unión con dominios trivariables y sus usos | |
| EP2209495A4 (de) | Taz/wwtr1 zur diagnose und behandlung von krebs | |
| ATE555384T1 (de) | Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika | |
| EP2257155A4 (de) | Kryokonservierung von biologischen zellen und geweben | |
| BR112013009713A2 (pt) | método para identificação de alta produtividade antagonistas microbianos contra patógenos | |
| BRPI1006270A8 (pt) | ''anticorpo anti a5b1, molécula de ácido nucleio isolado, célula hospedeira, método de produção de um anticorpo anti a5b1, imunoconjugado, composição farmacêutica, método de detecção de proteína a5b1, método de tratamento de um indivíduo e kit de detecção de a5b1 | |
| CU20120126A7 (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
| CY1115640T1 (el) | Διαγνωση και αγωγη εναντι της σχιζοφρενειας | |
| DE602005006990D1 (de) | Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen | |
| ATE414277T1 (de) | Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen | |
| BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
| BR112019003147A2 (pt) | uso de um marcador, métodos para identificar uma célula-tronco neural de mamífero e/ou uma célula progenitora neural de mamífero, para isolar uma célula-tronco neural de mamífero e/ou uma célula progenitora neural de mamífero, para determinar se um composto de teste modula uma diferenciação de célula-tronco neural de mamífero e/ou de célula progenitora neural de mamífero in vitro, para produzir uma população isolada de células de mamífero in vitro, para tratar doença ou dano e/ou prevenir e proteger contra dano no sistema nervoso em um indivíduo, para tratar um distúrbio mental ou comportamental em um indivíduo e para determinar as características de uma área danificada ou doente do snc em um paciente, cultura celular in vitro, cultura em suspensão, marcador para células-tronco neurais de mamífero e/ou para células progenitoras neurais de mamífero, e, composição. | |
| BRPI1008762B8 (pt) | métodos para seleção de células de mamífero expressando uma proteína heteróloga, para produzir um produto de interesse e uso de um meio de cultura seletivo | |
| BR112012028010A2 (pt) | anticorpo isolado, célula, ácido nucleíco isolado, método de identificação de um primeiro anticorpo que se liga a um epítopo antigênico tat425 ligado or um anticorpo, métodos de inibir o crescimento de uma célula, de tratamento terapêutico de determinação da presença de uma proteína de tat425 e de diagnóstico da presença de um tumor em um mamífero |